Applications of Glyconanoparticles as "sweet" Glycobiological Therapeutics and Diagnostics

Advances in Polymer Science

Volumn 254, Issue , 2013, Pages 297-342

  Kottari, Naresh ^a   Chabre, Yoann M ^a   Sharma, Rishi ^a   Roy, René ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Diagnostics; Glycodendrimers; Glyconanoparticles; Quantum dots; Therapeutics

Indexed keywords

EID: 84884645943     PISSN: 00653195     EISSN: None     Source Type: Book Series    
DOI: 10.1007/12_2012_208     Document Type: Article

References (132)

1. Wang X, Ramström O, Yan M (2010) Glyconanomaterials: synthesis, characterization, and ligand presentation. Adv Mater 22:1946-1953
2. Doane TL, Burda C (2012) The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 41:2885-2911
3. Narain R (ed) (2011) Engineered carbohydrate-based materials for biomedical applications-Polymers, surfaces, dendrimers, nanoparticles, and hydrogels. Wiley, Hoboken
4. Marradi M, Garcia I, Penadés S (2011) Carbohydrate-based nanoparticles for potential applications in medicine. Prog Mol Biol Transl Sci 104:141-173
5. Garcia I, Gallo J, Marradi M et al (2011) Glyconanoparticles: new nanomaterials for biological applications. In: Narain R (ed) Engineered carbohydrate-based materials for biomedical applications-polymers, surfaces, dendrimers, nanoparticles, and hydrogels. Wiley, Hoboken
6. El-Boubbou HX, Huang X (2011) Glyco-nanomaterials: translating insights from the "sugar code" to biomedical applications. Curr Med Chem 18:2060-2078
7. Garcia I, Marradi M, Penadés S (2010) Glyconanoparticles: multifunctional nanomaterials for biomedical applications. Nanomedicine 5:777-792
8. De la Fuente JM, Penadés S (2006) Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta 1760:636-651
9. Cipolla L, Peri F, Airoldi C (2008) Glycoconjugates in cancer therapy. Anticancer Agents Med Chem 8:92-121
10. Newkome GR, Moorefield CN, Vögtle F (2001) Dendrimers and dendrons: concepts, synthesis, applications. Wiley, New York
11. Fréchet JMJ, Tomalia D (2001) Dendrimers and other dendritic polymers. Wiley, New York
12. Buhleier E, Wehner W, Vögtle F (1978) "Cascade"-and "Nonskid-Chain-like" syntheses of molecular cavity topologies. Synthesis 1978:155-158
13. Newkome GR, Z-q Y, Baker GR et al (1985) Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol. J Org Chem 50:2004-2006
14. Tomalia DA, Baker H, Dewald J et al (1985) A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117-132
15. Haag R, Kratz F (2006) Polymer therapeutics: concepts and applications. Angew Chem Int Ed Engl 45:1198-1215
16. Tekade RK, Kumar PV, Jain NK (2009) Dendrimers in oncology: an expanding horizon. Chem Rev 109:49-87
17. Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57: 2215-2237
18. Boas U, Christensen JB, Heegaard PMH (2006) Dendrimers in medicine and biotechnology: new molecular tools. RSC Publishing, Cambridge
19. Roy R, Zanini D, Meunier SJ et al (1993) Solid phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin. J Chem Soc Chem Commun 1993:1869-1872
20. Lundquist JL, Toone EJ (2002) The cluster glycoside effect. Chem Rev 102:555-578
21. Roy R (1996) Syntheses and some applications of chemically defined multivalent glycoconjugates. Curr Opin Struct Biol 6:692-702
22. Chabre YM, Roy R (2010) Design and creativity in synthesis of multivalent neoglycoconjugates. Adv Cabohydr Chem Biochem 63:165-393
23. Chabre YM, Roy R (2008) Recent trends in glycodendrimer syntheses and applications. Curr Top Med Chem 8:1237-1285
24. Roy R (2003) A decade of glycodendrimer chemistry. Trends Glycosci Glycotechnol 15: 291-310
25. Touaibia M, Roy R (2007) Glycodendrimers as anti-adhesin drugs against type 1 fimbriated E. coli uropathogenic infections. Mini Rev Med Chem 7:1270-1283
26. Nepogodiev SA, Stoddart JF (2003) Glycodendrimers: chemical aspects. Adv Macromol Carbohydr Res 2:191-239
27. Röckendorf N, Lindhorst TK (2001) Glycodendrimers. Top Curr Chem 217:201-238
28. Cloninger MJ (2002) Biological applications of dendrimers. Curr Opin Chem Biol 6:42-748
29. Bezouska K (2002) Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). Rev Mol Biotechnol 90:269-290
30. Turnbull WB, Stoddart JF (2002) Design and synthesis of glycodendrimers. Rev Mol Biotechnol 90:231-255
31. Li Y, Cheng Y, Xu T (2007) Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. Curr Drug Discov Technol 4:246-254
32. Tanaka K, Siwu ERO, Minami K et al (2010) Noninvasive imaging of dendrimer-type N-glycan clusters: in vivo dynamics dependence on oligosaccharide structure. Angew Chem Int Ed 49:8195-8200
33. Kamerling JP, Boons GJ, Lee YC, Suzuki A, Taniguchi N, Voragen AGJ (eds) (2007) Analysis of glycans, polysaccharide functional properties & biochemistry of glycoconjugate glycans, carbohydrate-mediated interactions: comprehensive glycoscience: From Chemistry to Systems Biology, vol. II and III. Elsevier, Amsterdam
34. Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670-673
35. Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7:255-266
36. Shiao TC, Roy R (2012) Glycodendrimers as functional antigens and antitumor vaccines. New J Chem 36:324-339
37. Toyokuni T, Singhal AK (1995) Synthetic carbohydrate vaccines based on tumour-associated antigens. Chem Soc Rev 24:231-242
38. Toyokuni T, Dean B, Cai S et al (1994) Synthetic vaccines: synthesis of a dimeric Tn antigenlipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins. J Am Chem Soc 116:395-396
39. Kaiser A, Gaidzik N, Becker T et al (2010) Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the toll-like receptor 2. Angew Chem Int Ed 49:3688-3692
40. Kudryashov V, Glunz PW, Williams LJ et al (2001) Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody response to LewisY conjugates in mice. Proc Natl Acad Sci USA 98:3264-3269
41. Dumy P, Eggleston IM, Cervigni S et al (1995) A convenient synthesis of cyclic peptides as regioselectively addressable functionalized templates (RAFT). Tetrahedron Lett 36: 1255-1258
42. Renaudet O, BenMohamed L, Dasgupta G et al (2008) Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine. ChemMedChem 3:737-741
43. Bettahi I, Dasgupta G, Renaudet O et al (2009) Antitumor activity of a self-adjuvanting glycol-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes. Cancer Immunol Immunother 58:187-200
44. Renaudet O, Dasgupta G, Bettahi I et al (2010) Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity. PLoS One 5:e11216
45. Jeon I, Lee D, Krauss IJ et al (2009) A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ringclosing metathesis. J Am Chem Soc 131:14337-14344
46. Fiore M, Thomas B, Duléry V et al (2012) Synthesis of multi-antigenic platforms as vaccine candidates against cancers. New J Chem. doi:10. 1039/C2NJ40972K
47. Bossu I,S ? ulc M, Kr?enek K et al (2011) Dendri-RAFTs: a second generation of cyclopeptidebased glycoclusters. Org Biomol Chem 9:1948-1959
48. André S, Renaudet O, Bossu I et al (2011) Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells. J Pept Sci 17:427-437
49. Kroto HW, Heath JR, O' Brien SCO et al (1985) C60: buckminsterfullerene. Nature 318: 162-163
50. Giacalone F, Martin N (2006) Fullerene polymers: synthesis and properties. Chem Rev 106: 5136-5190
51. Jensen AW, Wilson SR, Schuster DI (1996) Biological applications of fullerenes. Bioorg Med Chem 4:767-779
52. Da Ros T, Prato M (1999) Medicinal chemistry with fullerenes and fullerene derivatives. Chem Commun 1999:663-669
53. Bosi S, Da Ros T, Spalluto G et al (2003) Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 38:913-923
54. Marchesan S, Da Ros T, Spalluto G et al (2005) Anti-HIV properties of cationic fullerene derivatives. Bioorg Med Chem Lett 15:3615-3618
55. Chabre YM, Roy R (2011) Solving promiscuous protein carbohydrate recognition domains with multivalent glycofullerenes. In: Renaudet O, Spinelli N (eds) Synthesis and biological applications of glycoconjugates. Bentham Science, Oak Park, pp. 64-77
56. Wennekes T, van den Berg RJBHN, Bonger KM et al (2010) Synthesis and evaluation of dimeric lipophilic iminosugars as inhibitors of glucosylceramide metabolism. Tetrahedron Asymmetry 20:836-846
57. Lohse A, Jensen KB, Lundgren K, Bols M (1999) Synthesis and deconvolution of the first combinatorial library of glycosidase inhibitors. Bioorg Med Chem 7:1965-1971
58. Compain P, Decroocq C, Iehl J et al (2010) Glycosidase inhibition with fullerene iminosugar balls: a dramatic multivalent effect. Angew Chem Int Ed Engl 49:5753-5756
59. Diot J, Garcia-Moreno MI, Gouin SG et al (2009) Multivalent iminosugars to modulate affinity and selectivity for glycosidases. Org Biomol Chem 7:357-363
60. Durka M, Buffet K, Iehl J et al (2012) The inhibition of liposaccharide heptosyltransferase WaaC with multivalent glycosylated fullerenes: a new mode of glycosyltransferase inhibition. Chem Eur J 18:641-651
61. Escaich S (2008) Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol 12:400-408
62. Moreau F, Desroy N, Genevard JM et al (2008) Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors. Bioorg Med Chem Lett 18:4022-4026
63. Tasis D, Tagmatarchis N, Bianco A et al (2006) Chemistry of carbon nanotubes. Chem Rev 106:1105-1136
64. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674-679
65. Martin CR, Kohli P (2003) The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2:29-37
66. Lin Y, Taylor S, Li H et al (2004) Advances toward bioapplications of carbon nanotubes. J Mater Chem 5:27-541
67. Prato M, Kostarelos K, Bianco A (2008) Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 41:60-68
68. Pastorin G, Kostarelos K, Prato M et al (2005) Functionalized carbon nanotubes: towards the delivery of therapeutic molecules. J Biomed Nanotechnol 1:133-142
69. Pantarotto D, Singh R, McCarthy D et al (2004) Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed 43:5242-5246
70. Shi Kam NW, Jessop TC, Wender PA et al (2004) Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 126:6850-6851
71. Bianco A, Kostarelos K, Partidos CD et al (2005) Biomedical applications of functionalised carbon nanotubes. Chem Commun 2005:571-577
72. Gorityala BK, Ma J, Wang X (2010) Carbohydrate functionalized carbon nanotubes and their applications. Chem Soc Rev 39:2925-2934
73. Bandaru NM, Voelcker NH (2012) Glycoconjugate-functionalized carbon nanotubes in biomedicine. J Mater Chem 22:8748-8758
74. Wu P, Chen X, Hu N et al (2008) Biocompatible carbon nanotubes generated by functionalization with glycodendrimers. Angew Chem Int Ed 47:5022-5025
75. Chen X, Lee GS, Zettl A et al (2004) Biomimetic engineering of carbon nanotubes by using cell surface mucin mimics. Angew Chem Int Ed 43:6112-6116
76. Hong SY, Tobias G, Al-Jamal KT et al (2010) Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater 9:485-490
77. Vedala H, Chen Y, Cecioni S et al (2010) Nanoelectronic detection of lectin-carbohydrate interactions using carbon nanotubes. Nano Lett 11:170-175
78. Chen Y, Vedala H, Kotchey GP et al (2012) Electronic detection of lectins using carbohydrate-functionalized nanostructures: graphene versus carbon nanotubes. ACS Nano 6:760-770
79. Brust M, Walker M, Bethell D et al (1994) Synthesis of thiol-derivatized gold nanoparticles in a 2-phase liquid-liquid system. J Chem Soc Chem Commun 1994:801-802
80. Marradi M, Chiodo F, Garc?á I et al (2011) Glycoliposomes and metallic glyconanoparticles in glycoscience. In: Renaudet O, Spinelli N (eds) Synthesis and biological applications of glycoconjugates. Bentham Science, Oak Ridge, pp 164-202
81. Chang-Ming D (2011) Glyconanoparticles for biomedical applications. Combin Chem High Throughput Screen 14:173-181
82. Marradi M, Martin-Lomas M, Penadés S (2010) Glyconanoparticles: polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem 64:211-290
83. de la Fuente JM, Barrientos AG, Rojas TC et al (2001) Gold glyconanoparticles as watersoluble polyvalent models to study carbohydrate interactions. Angew Chem Int Ed 40: 2257-2261
84. Ojeda R, de Paz JL, Barrientos AG et al (2007) Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res 342:448-459
85. Brinas RP, Sundgren A, Sahoo P et al (2012) Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. Bioconjug Chem 23:1513-1523
86. Marradi M, Alcántara D, de la Fuente JM et al (2009) Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars. Chem Commun 2009:3922-3924
87. Schofield CL, Field RA, Russell DA (2007) Glyconanoparticles for the colorimetric detection of cholera toxin. Anal Chem 79:1356-1361
88. Turnbull WB, Precious BL, Homans SW (2004) Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. J Am Chem Soc 126:1047-1054
89. Reynolds M, Marradi M, Imberty A et al (2012) Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL. Chem Eur J 18:4264-4273
90. Weingart JJ, Sun XL (2011) Glyco-functionalized quantum dots. ACS Symp Ser 1091: 105-121
91. Svarovsky SA, Barchi JJ Jr (2007) De novo sunthesis of biofunctional carbohydrateencapsulated quantum dots. ACS Symp Ser 960:375-392
92. Dong CM (2011) Glyconanoparticles for biomedical applications. Comb Chem High Throughput Screen 14:173-181
93. Ohyanagi T, Nagahori N, Shimawaki K et al (2011) Importance of sialic acid residues illuminated by live animal imaging using phosphorylcholine self-assembled monolayercoated quantum dots. J Am Chem Soc 133:12507-12517
94. Malvindi MA, Corato RD, Curcio A et al (2011) Multiple functionalization of fluorescent nanoparticles for specific biolabeling and drug delivery of dopamine. Nanoscale 3:5110-5119
95. Yang Y, Yu M, Yan T-T et al (2010) Characterization of multivalent lactose quantum dots and its application in carbohydrate-protein interactions study and cell imaging. Bioorg Med Chem 18:5234-5240
96. Gupta AK, Gupta M(2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995-4021
97. El-Boubbou K, Zhu DC, Vasileiou C, Borhan B et al (2010) Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. J Am Chem Soc 132:4490-4499
98. Gallo J, Garc?á I, Genicio N, Padro D, Penadés S (2011) Specific labelling of cell populations in blood with targeted immuno-fluorescent/magnetic glyconanoparticles. Biomaterials 32:9818-9825
99. Jølck RI, Feldborg LN, Andersen S et al (2011) Engineering liposomes and nanoparticles for biological targeting. Adv Biochem Eng Biotechnol 125:251-280
100. Ahn DJ, Kim J-M (2008) Fluorogenic polydiacetylene supramolecules: immobilization, micropatterning, and application to label-free chemosensors. Acc Chem Res 41:805-816
101. Deng J, Sheng Z, Zhou K et al (2009) Construction of effective receptor for recognition of Avian influenza H5N1 protein HA1 by assembly of monohead glycolipids on polydiacetylene vesicle surface. Bioconjug Chem 20:533-537
102. Zhu J, Xue J, Guo Z et al (2007) Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Bioconjug Chem 18:1366-1369
103. McEver RP, Cummings RD (1997) Cell adhesion in vascular biology. J Clin Invest 110: 485-491
104. Li F, Erickson HP, James JA et al (1996) Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes form monoclonal antibodies. J Biol Chem 271:6342-6348
105. Ma Y, Sobkiv I, Gruzdys V et al (2012) Liposomal glyco-microarray for studying glycolipid-protein interactions. Anal Bioanal Chem 404:51-58
106. van Dongen SFM, de Hoog H-PM, Peters RJRW et al (2009) Biohybrid polymer capsules. Chem Rev 109:6212-6274
107. Richard C, Chaumet-Riffaud P, Belland A et al (2009) Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging. Int J Pharm 379:301-308
108. Chabaud E, Barthélémy P, Mora N et al (1998) Stabilization of integral membrane proteins in aqueous solution using fluorinated surfactants. Biochimie 80:515-530
109. Bó AGD, Soldi V, Giacomelli FC et al (2012) Self-assembly of amphiphilic glycoconjugates into lectin-adhesive nanoparticles. Langmuir 28:1418-1426
110. Roy R (1996) Blue-prints, syntheses and applications of glycopolymers. Trends Glycosci Glycotechnol 8:79-99
111. Ladmiral V, Melia E, Haddleton DM (2004) Synthetic glycopolymers: an overview. Eur Polym J 40:431-449
112. Roy R (1996) Syntheses and some applications of chemically defined multivalent glycoconjugates. Curr Opin Struct Biol 65:692-702
113. Chabre YM, Roy R (2009) The Chemist's way to prepare multivalency. In: Gabius HJ (ed) The sugar code: fundamentals of glycosciences. Wiley-Blackwell, Weinheim, pp 53-70
114. Pearson S, Scarano W, Stenzel MH (2012) Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents. Chem Commun 48:4695-4697
115. Gaujoux-Viala C, Smolen JS, Landewé R et al (2010) Extended report: Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:1004-1009
116. Jiang X, Housni A, Gody G et al (2010) Synthesis of biotinylated ?-D-mannoside or N-acetyl ?-D-glucosaminoside decorated gold nanoparticles: study of their biomolecular recognition with Con A and WGA lectins. Bioconjug Chem 21:521-530
117. McGilvray KL, Decan MR, Wang D et al (2006) Facile photochemical synthesis of unprotected aqueous gold nanoparticles. J Am Chem Soc 128:15980-15981
118. Wang Y, Zhang X, Han Y et al (2012) pH-and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin. Carbohydr Polym 89:124-131
119. Egawa Y, Seki T, Takahashi S et al (2011) Electrochemical and optical sugar sensors based on phenylboronic acid and its derivatives. Mater Sci Eng C 31:1257-1264
120. Oh JK, Bencherif SA, Matyjaszewski K (2009) Atom transfer radical polymerization in inverse miniemulsion: a versatile route toward preparation and functionalization of microgels/nanogels for targeted drug delivery applications. Polymer 50:4407-4423
121. Ebara M (2011) Carbohydrate-derived hydrogels and microgels. In: Narain R (ed) Engineered carbohydrate-based materials for biomedical applications-polymers, surfaces, dendrimers, nanoparticles, and hydrogels. Wiley, Hoboken
122. Ahmed M, Narain R (2012) Intracellular delivery of DNA and enzyme in active form using degradable carbohydrate-based nanogels. Mol Pharm 9:3160-3170
123. Wu W, Shen J, Banerjee P et al (2010) Chitosan-based responsive hybrid nanogels for integration of optical pH-sensing, tumor cell imaging and controlled drug delivery. Biomaterials 31:8371-8381
124. Dutta PK (ed) (2005) Chitin and chitosan opportunities and challenges. SSM International Publication, Midnapore
125. Mizrahy S, Peer D (2012) Polysaccharides as building blocks for nanotherapeutics. Chem Soc Rev 41:2623-2640
126. Bhaw-Luximon A (2011) Modified natural polysaccharides as nanoparticulate drug delivery devices. In: Narain R (ed) Engineered carbohydrate-based materials for biomedical applications-polymers, surfaces, dendrimers, nanoparticles, and hydrogels. Wiley, Hoboken
127. Park SY, Baik HJ, Oh YT et al (2011) A smart polysaccharide/drug conjugate for photodynamic therapy. Angew Chem Int Ed 50:1644-1647
128. Bogdan N, Vetrone F, Roy R et al (2010) Carbohydrate-coated lanthanide-doped upconverting nanoparticles for lectin recognition. J Mater Chem 20:7543-7550
129. Pfaff A, Schallon A, Ruhland TM et al (2011) Magnetic and fluorescent glycopolymer hybrid nanoparticles for intranuclear optical imaging. Biomacromolecules 12:3805-3811
130. Pfaff A, Shinde VS, Lu Y et al (2011) Glycopolymer-grafted polystyrene nanospheres. Macromol Biosci 11:199-210
131. Gabius HJ, André S, Jiménez-Barbero J et al (2011) From lectin structure to functional glycomics: principles of the sugar code. Trends Biochem Sci 36:288-303
132. Gabius HJ (ed) (2009) The sugar code: fundamentals of glycosciences. Wiley-Blackwell, Weinheim